These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1977852)

  • 1. Reduction of serum calcium by sodium sulfonated polystyrene resin.
    Ng YY; Wu SC; Cheng CT; Yang WC; Chung HM; Huang TP
    J Formos Med Assoc; 1990 May; 89(5):399-402. PubMed ID: 1977852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ion exchange resins on the composition of milk].
    Bonnet L; Goudable J; Accominotti M; Fontaine D; Cochat P
    Nephrologie; 1997; 18(7):287-9. PubMed ID: 9496569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients.
    Johnson K; Cazee C; Gutch C; Ogden D
    Clin Nephrol; 1976 Jun; 5(6):266-8. PubMed ID: 1277599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP; King AJ; Kumaraswamy P; Caldwell JS; Korner P; Blanks RC; Jacobs JW
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):244-253. PubMed ID: 29130735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K; Flynn J; Okamura D; Zhou L
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion.
    Emmett M; Hootkins RE; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Gastroenterology; 1995 Mar; 108(3):752-60. PubMed ID: 7875477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia.
    Meyer I
    ANNA J; 1993 Feb; 20(1):93-5. PubMed ID: 8431031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
    Linakis JG; Savitt DL; Lockhart GR; Trainor B; Lacouture PG; Lewander WJ
    Am J Emerg Med; 1995 Nov; 13(6):669-70. PubMed ID: 7575808
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of the cation exchange resin, sodium polystyrene sulfonate, to decrease iron absorption.
    Shepherd G; Klein-Schwartz W; Burstein AH
    J Toxicol Clin Toxicol; 2000; 38(4):389-94. PubMed ID: 10930055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum magnesium levels in chronic renal failure. Clinical significance and correlation with sodium potassium and calcium.
    Sharma SK; Singh R; Patney NL; Singh JB; Sharma AP
    J Assoc Physicians India; 1990 Aug; 38(8):569-71. PubMed ID: 2246198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease.
    Gruy-Kapral C; Emmett M; Santa Ana CA; Porter JL; Fordtran JS; Fine KD
    J Am Soc Nephrol; 1998 Oct; 9(10):1924-30. PubMed ID: 9773794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis.
    Rivard AL; Raup SM; Beilman GJ
    JPEN J Parenter Enteral Nutr; 2004; 28(2):76-8. PubMed ID: 15080600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a potassium-specific adsorbent for direct hemoperfusion.
    Terai C; Shimizu S; Matsushima S; Tanaka I; Okada Y; Miyahara T; Nakaji S
    Artif Organs; 1996 Nov; 20(11):1227-32. PubMed ID: 8908334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hyperkalemia in renal insufficiency with cation exchange resin. Experience with use of sodium polystyrene sulfonate].
    Osawa A; Okoshi M; Higuchi J; Yamayoshi W
    Hinyokika Kiyo; 1969 Sep; 15(9):645-51. PubMed ID: 5388724
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro binding of iron with the cation-exchange resin sodium polystyrene sulfonate.
    O'Connor TA; Gruner BA; Gehrke JC; Watling SM; Gehrke CW
    Ann Emerg Med; 1996 Nov; 28(5):504-7. PubMed ID: 8909271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Necrosis Associated with Orally Administered Calcium Polystyrene Sulfonate Without Sorbitol.
    Goutorbe P; Montcriol A; Lacroix G; Bordes J; Meaudre E; Souraud JB
    Ann Pharmacother; 2011 Feb; 45(2):e13. PubMed ID: 21304040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sodium, potassium, calcium in chronic renal insufficiency].
    Locatelli F; Ponti R; Di Filippo S
    G Ital Cardiol; 1990 May; 20(5):449-62. PubMed ID: 2210169
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of water soaking and/or sodium polystyrene sulfonate addition on potassium content of foods.
    Picq C; Asplanato M; Bernillon N; Fabre C; Roubeix M; Ricort JM
    Int J Food Sci Nutr; 2014 Sep; 65(6):673-7. PubMed ID: 24720622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of partusisten in prevention of hyperkalemia in patients with chronic glomerulonephritis with initial forms of renal failure].
    Skinskiĭ IM; Komandenko MS; Shulutko BI; Zamoskovskaia GA
    Klin Med (Mosk); 1991 Oct; 69(10):83-4. PubMed ID: 1766229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.